83 FR 46490 - Agency Forms Undergoing Paperwork Reduction Act Review
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention Federal Register Volume 83, Issue 178 (September 13, 2018)
Centers for Disease Control and Prevention
Federal Register Volume 83, Issue 178 (September 13, 2018)
| Page Range | 46490-46493 | |
| FR Document | 2018-19902 |
[Federal Register Volume 83, Number 178 (Thursday, September 13, 2018)] [Notices] [Pages 46490-46493] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-19902] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day-18-0666] Agency Forms Undergoing Paperwork Reduction Act Review In accordance with the Paperwork Reduction Act of 1995, the Centers for Disease Control and Prevention (CDC) has submitted the information collection request titled National Healthcare Safety Network to the Office of Management and Budget (OMB) for review and approval. CDC previously published a ``Proposed Data Collection Submitted for Public Comment and Recommendations'' notice on May 11, 2018 to obtain comments from the public and affected agencies. CDC received one comment related to the previous notice. This notice serves to allow an additional 30 days for public and affected agency comments. CDC will accept all comments for this proposed information collection project. The Office of Management and Budget is particularly interested in comments that: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including, through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639-7570 or send an email to [email protected]. Direct written comments and/or suggestions regarding the items contained in this notice to the Attention: CDC Desk Officer, Office of Management and Budget, 725 17th Street, NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide written comments within 30 days of notice publication. Proposed Project National Healthcare Safety Network (0920-0666, Expiration Date 1/ 31/2021)--Revision--National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC). Background and Brief Description NHSN is a public health surveillance system that collects, analyzes, reports, and makes available data for monitoring, measuring, and responding to healthcare associated infections (HAIs), antimicrobial use and resistance, blood transfusion safety events, and the extent to which healthcare facilities adhere to infection prevention practices and antimicrobial stewardship. Specifically, resulting data estimates the magnitude of Healthcare Associated Infections (HAI), monitor HAI trends, and facilitate inter-facility and intra-facility comparisons with risk-adjusted data used for local quality improvement activities. The data will be used to detect changes in the epidemiology of adverse events resulting from new and current medical therapies and changing risks. The NHSN currently consists of six components: Patient Safety, Healthcare Personnel Safety, Biovigilance, Long-Term Care Facility (LTCF), Outpatient Procedure Component, and Dialysis. Changes were made to 34 data collection facility surveys with this revision ICR. CDC revised three annual facility surveys for the Patient Safety component for Hospitals, Long-Term Acute Care Facilities, and Inpatient Rehabilitation Facilities. CDC's revisions clarify the reporting requirements for the data collected on fungal testing, facility locations, and laboratory testing locations. Additionally, corresponding response [[Page 46491]] options for these questions have been revised to include updated testing methods used by facilities to capture current HAI specific data specification requirements for NHSN. New required questions have been added to all Patient Safety component surveys. The new questions are designed to provide data on surveillance processes, policies, and standards that are used by reporting facilities to ensure that when an event is detected, the facility has the appropriate mechanism to conduct complete reporting. The Hospital Annual Survey added new required questions to provide data about neonatal antimicrobial stewardship practices because the focus of stewardship efforts in neonatology differ from the focus in adult and pediatric practice. Questions were removed and replaced on all three Patient Safety surveys to align better with the Core Elements of Hospital Antibiotic Stewardship Programs specified by CDC. The Core Elements defined by CDC are part of broad-based efforts by CDC and its healthcare and public health partners to combat the threat of antibiotic-resistant bacteria. The new Antibiotic Stewardship Program questions will provide additional data about operational features of the programs that hospitals have implemented, which in turn will enable CDC and its healthcare and public health partners to target their efforts to help invigorate and extend antibiotic stewardship. CDC is introducing a new optional survey form that is designed to be completed by state and local health departments that participate in HAI surveillance and prevention activities. This new form will provide data on legal and regulatory requirements that are pertinent to HAI reporting. CDC plans to include data the health department survey in its annual National and State Healthcare-Associated Infection Progress Report. The report helps identify the progress in HAI surveillance and prevention at the state and national levels. Data about the extent to which state health departments have validated HAI data that healthcare facilities in their jurisdiction report to NHSN and the extent of state and local health department HAI reporting requirements are important data for users of CDC's HAI Progress Report to consider when they are reviewing and interpreting data in the report. NHSN now includes a ventilator-associated event available for NICU locations, which requires additional denominator reporting, in which CDC has provided an option to accommodate facilities that are reporting requested data by updating the corresponding surveys. The Pediatric Ventilator-Associated Event (PedVAE) was removed from the survey because a single algorithm is used to detect PedVAE events. NHSN has made updates to the Antimicrobial Use and Resistance (AUR) data collection tools for the purposes of monitoring additional microorganisms and their antimicrobial susceptibility profiles. Use of these updates in AUR surveillance will provide important additional data for clinical and public health responses to mounting antibiotic resistance problems. The Long-term Care Facility Component (LTCF) will be updating three forms, two of which will include an update for facilities to document the ``CDI treatment start'' variable. Early CDI reporting data from nursing homes has shown exceptionally low event rates for many reporting facilities (e.g., zero events for six or more months). Since current CDI event detection is based on presence of a positive laboratory specimen, variability in the use of diagnostic testing as part of CDI management will have direct impact on the estimate of CDI burden in a facility (e.g., empiric treatment for CDI without confirmatory testing may result in the appearance of low disease burden). In order to determine whether low CDI event rates might be due to empiric CDI treatment practices, a new process measure will be incorporated into the monthly summary data on CDI for LTCFs. This measure, called ``CDI treatment starts,'' will allow providers to capture the number of residents started on antibiotic treatment for CDI that month based on clinical decisions (i.e., even those without a positive CDI test). This process measure should provide data on clinically-treated CDI in order to inform our understanding of CDI management practices and serve as a proxy for CDI burden in nursing homes. Overall, minor revisions have been made to a total of 34 forms within the package to clarify and/or update surveillance definitions, increase or decrease the number of reporting facilities, and add new forms. Finally, NHSN has achieved significant burden reduction with this ICR due to a decrease in the number of respondents for the Specialty Care Area (SCA) and Oncology (ONC) facilities reporting to NHSN. NHSN re-evaluated these reporting facilities and determined that approximately 2,000 SCA and ONC facilities are reporting to NHSN compared to the estimated 6,000 that was estimated last year. Additionally, NHSN streamlined many response options, which also attributed to a reduction in the overall burden. The previously approved NHSN package included 72 individual collection forms; the current revision request includes a total of 73 forms. The reporting burden will decrease by 109,745 hours, for a total of 5,393,725 hours. Estimated Annualized Burden Hours ---------------------------------------------------------------------------------------------------------------- Number of Average burden Type of respondents Form name Number of responses per per response respondents respondent (in hours) ---------------------------------------------------------------------------------------------------------------- Healthcare facility................ 57.100 NHSN Registration 2,000 1 5/60 Form. 57.101 Facility Contact 2,000 1 10/60 Information. 57.103 Patient Safety 6,000 1 75/60 Component--Annual Hospital Survey. 57.105 Group Contact 1,000 1 5/60 Information. 57.106 Patient Safety 6,000 12 15/60 Monthly Reporting Plan. 57.108 Primary Bloodstream 6,000 44 33/60 Infection (BSI). 57.111 Pneumonia (PNEU).... 1,800 72 30/60 57.112 Ventilator- 6,000 144 28/60 Associated Event. 57.113 Pediatric Ventilator- 100 120 30/60 Associated Event (PedVAE). 57.114 Urinary Tract 6,000 40 20/60 Infection (UTI). 57.115 Custom Event........ 600 91 35/60 57.116 Denominators for 6,000 12 4 Neonatal Intensive Care Unit (NICU). [[Page 46492]] 57.117 Denominators for 2,000 9 302/60 Specialty Care Area (SCA)/ Oncology (ONC). 57.118 Denominators for 6,000 60 302/60 Intensive Care Unit (ICU)/ Other locations (not NICU or SCA). 57.120 Surgical Site 6,000 36 35/60 Infection (SSI). 57.121 Denominator for 6,000 540 10/60 Procedure. 57.122 HAI Progress Report 55 1 45/60 State Health Department Survey. 57.123 Antimicrobial Use 1,000 12 5/60 and Resistance (AUR)- Microbiology Data Electronic Upload Specification Tables. 57.124 Antimicrobial Use 2,000 12 5/60 and Resistance (AUR)- Pharmacy Data Electronic Upload Specification Tables. 57.125 Central Line 100 100 25/60 Insertion Practices Adherence Monitoring. 57.126 MDRO or CDI 6,000 72 30/60 Infection Form. 57.127 MDRO and CDI 6,000 24 15/60 Prevention Process and Outcome Measures Monthly Monitoring. 57.128 Laboratory- 6,000 240 20/60 identified MDRO or CDI Event. 57.129 Adult Sepsis........ 50 250 25/60 57.137 Long-Term Care 2,600 1 2 Facility Component--Annual Facility Survey. 57.138 Laboratory- 2,600 12 20/60 identified MDRO or CDI Event for LTCF. 57.139 MDRO and CDI 2,600 12 20/60 Prevention Process Measures Monthly Monitoring for LTCF. 57.140 Urinary Tract 2,600 14 35/60 Infection (UTI) for LTCF. 57.141 Monthly Reporting 2,600 12 5/60 Plan for LTCF. 57.142 Denominators for 2,600 12 250/60 LTCF Locations. 57.143 Prevention Process 2,600 12 5/60 Measures Monthly Monitoring for LTCF. 57.150 LTAC Annual Survey.. 400 1 70/60 57.151 Rehab Annual Survey. 1,000 1 70/60 57.200 Healthcare Personnel 50 1 8 Safety Component Annual Facility Survey. 57.203 Healthcare Personnel 19,500 1 5/60 Safety Monthly Reporting Plan. 57.204 Healthcare Worker 50 200 20/60 Demographic Data. 57.205 Exposure to Blood/ 50 50 1 Body Fluids. 57.206 Healthcare Worker 50 30 15/60 Prophylaxis/Treatment. 57.207 Follow-Up Laboratory 50 50 15/60 Testing. 57.210 Healthcare Worker 50 50 10/60 Prophylaxis/Treatment- Influenza. 57.300 Hemovigilance Module 500 1 85/60 Annual Survey. 57.301 Hemovigilance Module 500 12 1/60 Monthly Reporting Plan. 57.303 Hemovigilance Module 500 12 70/60 Monthly Reporting Denominators. 57.305 Hemovigilance 500 10 10/60 Incident. 57.306 Hemovigilance Module 200 1 35/60 Annual Survey--Non-acute care facility. 57.307 Hemovigilance 500 4 20/60 Adverse Reaction--Acute Hemolytic Transfusion Reaction. 57.308 Hemovigilance 500 4 20/60 Adverse Reaction--Allergic Transfusion Reaction. 57.309 Hemovigilance 500 1 20/60 Adverse Reaction--Delayed Hemolytic Transfusion Reaction. 57.310 Hemovigilance 500 2 20/60 Adverse Reaction--Delayed Serologic Transfusion Reaction. 57.311 Hemovigilance 500 4 20/60 Adverse Reaction--Febrile Non-hemolytic Transfusion Reaction. 57.312 Hemovigilance 500 1 20/60 Adverse Reaction-- Hypotensive Transfusion Reaction. 57.313 Hemovigilance 500 1 20/60 Adverse Reaction-- Infection. 57.314 Hemovigilance 500 1 20/60 Adverse Reaction--Post Transfusion Purpura. 57.315 Hemovigilance 500 1 20/60 Adverse Reaction-- Transfusion Associated Dyspnea. 57.316 Hemovigilance 500 1 20/60 Adverse Reaction-- Transfusion Associated Graft vs. Host Disease. 57.317 Hemovigilance 500 1 20/60 Adverse Reaction-- Transfusion Related Acute Lung Injury. 57.318 Hemovigilance 500 2 20/60 Adverse Reaction-- Transfusion Associated Circulatory Overload. [[Page 46493]] 57.319 Hemovigilance 500 1 20/60 Adverse Reaction--Unknown Transfusion Reaction. 57.320 Hemovigilance 500 1 20/60 Adverse Reaction--Other Transfusion Reaction. 57.400 Outpatient Procedure 5,000 1 10/60 Component--Annual Facility Survey. 57.401 Outpatient Procedure 5,000 12 20/60 Component--Monthly Reporting Plan. 57.402 Outpatient Procedure 1,200 25 40/60 Component Same Day Outcome Measures. 57.403 Outpatient Procedure 1,200 12 40/60 Component--Monthly Denominators for Same Day Outcome Measures. 57.404 Outpatient Procedure 5,000 540 10/60 Component--SSI Denominator. 57.405 Outpatient Procedure 5,000 36 35/60 Component--Surgical Site (SSI) Event. 57.500 Outpatient Dialysis 7,000 1 127/60 Center Practices Survey. 57.501 Dialysis Monthly 7,000 12 5/60 Reporting Plan. 57.502 Dialysis Event...... 7,000 60 25/60 57.503 Denominator for 7,000 12 10/60 Outpatient Dialysis. 57.504 Prevention Process 2,000 12 85/60 Measures Monthly Monitoring for Dialysis. 57.505 Dialysis Patient 325 75 10/60 Influenza Vaccination. 57.506 Dialysis Patient 325 5 10/60 Influenza Vaccination Denominator. 57.507 Home Dialysis Center 350 1 30/60 Practices Survey. ---------------------------------------------------------------------------------------------------------------- Jeffrey M. Zirger, Acting Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2018-19902 Filed 9-12-18; 8:45 am] BILLING CODE 4163-18-P
![46490 Federal Register / Vol. 83, No. 178 / Thursday, September 13, 2018 / Notices
research activities in the health field. monitoring of goals for the Year 2000, There is no cost to respondents other
Historically, data have been used 2010, and 2020 Healthy People than their time to participate. The total
extensively in the development and Objectives. annualized burden is 7,080 hours.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of Average Total
Number of responses burden per
Type of respondents Form name burden
respondents per response (in hours)
respondent (in hours)
Hospital Director of Health Informa- Initial Hospital Intake Questionnaire 150 1 1 150
tion Management (DHIM) or Direc-
tor of Health Information Tech-
nology (DHIT).
Hospital Chief Executive Officer Recruitment Survey Presentation .... 150 1 1 150
(CEO)/Chief Financial Officer
(CFO).
Hospital DHIM or DHIT ..................... Prepare and transmit UB–04 or 399 12 1 4,788
State File for Inpatient and Ambu-
latory.
Hospital DHIM or DHIT ..................... Prepare and transmit EHR for Inpa- 199 4 1 796
tient and Ambulatory.
Hospital CEO/CFO ............................ Annual Hospital Interview ................ 598 1 2 1,196
Total ........................................... ........................................................... ........................ ........................ ........................ 7,080
Jeffrey M. Zirger, (a) Evaluate whether the proposed Emerging and Zoonotic Infectious
Acting Chief, Information Collection Review collection of information is necessary Diseases (NCEZID), Centers for Disease
Office, Office of Scientific Integrity, Office for the proper performance of the Control and Prevention (CDC).
of the Associate Director for Science, Office functions of the agency, including
of the Director, Centers for Disease Control Background and Brief Description
whether the information will have
and Prevention. practical utility; NHSN is a public health surveillance
[FR Doc. 2018–19901 Filed 9–12–18; 8:45 am] (b) Evaluate the accuracy of the system that collects, analyzes, reports,
BILLING CODE 4163–18–P agencies estimate of the burden of the and makes available data for
proposed collection of information, monitoring, measuring, and responding
including the validity of the to healthcare associated infections
DEPARTMENT OF HEALTH AND methodology and assumptions used; (HAIs), antimicrobial use and resistance,
HUMAN SERVICES (c) Enhance the quality, utility, and blood transfusion safety events, and the
clarity of the information to be extent to which healthcare facilities
Centers for Disease Control and collected; adhere to infection prevention practices
Prevention (d) Minimize the burden of the and antimicrobial stewardship.
collection of information on those who Specifically, resulting data estimates the
[30Day–18–0666] are to respond, including, through the magnitude of Healthcare Associated
use of appropriate automated, Infections (HAI), monitor HAI trends,
Agency Forms Undergoing Paperwork electronic, mechanical, or other and facilitate inter-facility and intra-
Reduction Act Review technological collection techniques or facility comparisons with risk-adjusted
other forms of information technology, data used for local quality improvement
In accordance with the Paperwork activities. The data will be used to
e.g., permitting electronic submission of
Reduction Act of 1995, the Centers for detect changes in the epidemiology of
responses; and
Disease Control and Prevention (CDC) (e) Assess information collection adverse events resulting from new and
has submitted the information costs. current medical therapies and changing
collection request titled National To request additional information on risks. The NHSN currently consists of
Healthcare Safety Network to the Office the proposed project or to obtain a copy six components: Patient Safety,
of Management and Budget (OMB) for of the information collection plan and Healthcare Personnel Safety,
review and approval. CDC previously instruments, call (404) 639–7570 or Biovigilance, Long-Term Care Facility
published a ‘‘Proposed Data Collection send an email to omb@cdc.gov. Direct (LTCF), Outpatient Procedure
Submitted for Public Comment and written comments and/or suggestions Component, and Dialysis.
Recommendations’’ notice on May 11, regarding the items contained in this Changes were made to 34 data
2018 to obtain comments from the notice to the Attention: CDC Desk collection facility surveys with this
public and affected agencies. CDC Officer, Office of Management and revision ICR. CDC revised three annual
received one comment related to the Budget, 725 17th Street, NW, facility surveys for the Patient Safety
previous notice. This notice serves to Washington, DC 20503 or by fax to (202) component for Hospitals, Long-Term
daltland on DSKBBV9HB2PROD with NOTICES
allow an additional 30 days for public 395–5806. Provide written comments Acute Care Facilities, and Inpatient
and affected agency comments. within 30 days of notice publication. Rehabilitation Facilities. CDC’s
CDC will accept all comments for this revisions clarify the reporting
proposed information collection project. Proposed Project requirements for the data collected on
The Office of Management and Budget National Healthcare Safety Network fungal testing, facility locations, and
is particularly interested in comments (0920–0666, Expiration Date 1/31/ laboratory testing locations.
that: 2021)—Revision—National Center for Additionally, corresponding response
VerDate Sep<11>2014 19:20 Sep 12, 2018 Jkt 244001 PO 00000 Frm 00015 Fmt 4703 Sfmt 4703 E:\FR\FM\13SEN1.SGM 13SEN1](https://thefederalregister.org/doc/83_FR_46668/page/1.svg)
![Federal Register / Vol. 83, No. 178 / Thursday, September 13, 2018 / Notices 46493
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Average
Number of
Number of burden per
Type of respondents Form name responses per
respondents response
respondent (in hours)
57.319 Hemovigilance Adverse Reaction—Unknown Trans- 500 1 20/60
fusion Reaction.
57.320 Hemovigilance Adverse Reaction—Other Trans- 500 1 20/60
fusion Reaction.
57.400 Outpatient Procedure Component—Annual Facility 5,000 1 10/60
Survey.
57.401 Outpatient Procedure Component—Monthly Report- 5,000 12 20/60
ing Plan.
57.402 Outpatient Procedure Component Same Day Out- 1,200 25 40/60
come Measures.
57.403 Outpatient Procedure Component—Monthly Denomi- 1,200 12 40/60
nators for Same Day Outcome Measures.
57.404 Outpatient Procedure Component—SSI Denomi- 5,000 540 10/60
nator.
57.405 Outpatient Procedure Component—Surgical Site 5,000 36 35/60
(SSI) Event.
57.500 Outpatient Dialysis Center Practices Survey ............. 7,000 1 127/60
57.501 Dialysis Monthly Reporting Plan ................................ 7,000 12 5/60
57.502 Dialysis Event ............................................................. 7,000 60 25/60
57.503 Denominator for Outpatient Dialysis .......................... 7,000 12 10/60
57.504 Prevention Process Measures Monthly Monitoring 2,000 12 85/60
for Dialysis.
57.505 Dialysis Patient Influenza Vaccination ....................... 325 75 10/60
57.506 Dialysis Patient Influenza Vaccination Denominator 325 5 10/60
57.507 Home Dialysis Center Practices Survey .................... 350 1 30/60
Jeffrey M. Zirger, response to the notice. This notice third party may not wish to be posted,
Acting Chief, Information Collection Review solicits comments on the information such as medical information, your or
Office, Office of Scientific Integrity, Office collection associated with the Food anyone else’s Social Security number, or
of the Associate Director for Science, Office Contact Substance Notification Program. confidential business information, such
of the Director, Centers for Disease Control as a manufacturing process. Please note
DATES: Submit either electronic or
and Prevention. that if you include your name, contact
written comments on the collection of
[FR Doc. 2018–19902 Filed 9–12–18; 8:45 am] information, or other information that
information by November 13, 2018.
BILLING CODE 4163–18–P
ADDRESSES: You may submit comments
identifies you in the body of your
as follows. Please note that late, comments, that information will be
untimely filed comments will not be posted on https://www.regulations.gov.
DEPARTMENT OF HEALTH AND • If you want to submit a comment
HUMAN SERVICES considered. Electronic comments must
with confidential information that you
be submitted on or before November 13,
do not wish to be made available to the
Food and Drug Administration 2018. The https://www.regulations.gov
public, submit the comment as a
electronic filing system will accept written/paper submission and in the
[Docket No. FDA–2012–N–0294]
comments until midnight Eastern Time manner detailed (see ‘‘Written/Paper
Agency Information Collection at the end of November 13, 2018. Submissions’’ and ‘‘Instructions’’).
Activities; Proposed Collection; Comments received by mail/hand
Comment Request; Food Contact delivery/courier (for written/paper Written/Paper Submissions
Substance Notification Program submissions) will be considered timely Submit written/paper submissions as
if they are postmarked or the delivery follows:
AGENCY: Food and Drug Administration, service acceptance receipt is on or • Mail/Hand Delivery/Courier (for
HHS. before that date. written/paper submissions): Dockets
ACTION: Notice. Electronic Submissions Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
SUMMARY: The Food and Drug Submit electronic comments in the Lane, Rm. 1061, Rockville, MD 20852.
Administration (FDA or Agency) is following way: • For written/paper comments
announcing an opportunity for public • Federal eRulemaking Portal: submitted to the Dockets Management
comment on the proposed collection of https://www.regulations.gov. Follow the Staff, FDA will post your comment, as
certain information by the Agency. instructions for submitting comments. well as any attachments, except for
Under the Paperwork Reduction Act of Comments submitted electronically, information submitted, marked and
daltland on DSKBBV9HB2PROD with NOTICES
1995 (PRA), Federal Agencies are including attachments, to https:// identified, as confidential, if submitted
required to publish notice in the www.regulations.gov will be posted to as detailed in ‘‘Instructions.’’
Federal Register concerning each the docket unchanged. Because your Instructions: All submissions received
proposed collection of information, comment will be made public, you are must include the Docket No. FDA–
including each proposed extension of an solely responsible for ensuring that your 2012–N–0294 for ‘‘Agency Information
existing collection of information, and comment does not include any Collection Activities; Proposed
to allow 60 days for public comment in confidential information that you or a Collection; Comment Request; Food
VerDate Sep<11>2014 19:20 Sep 12, 2018 Jkt 244001 PO 00000 Frm 00018 Fmt 4703 Sfmt 4703 E:\FR\FM\13SEN1.SGM 13SEN1](https://thefederalregister.org/doc/83_FR_46668/page/4.svg)
Document Created: 2018-09-13 01:02:07
Document Modified: 2018-09-13 01:02:07
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| FR Citation | 83 FR 46490 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR